Free Newsletter

FierceVaccines is a weekly update on the vaccine industry, with a special focus on the innovations revolutionizing the development and production of vaccines. Join thousands of lab research professionals who get FierceVaccines via weekly email. Sign up today!

About | View Sample | Privacy

Hottest Products

Compare Top Solutions in:

Evaluate more than 400,000 products >>

Featured Jobs

Clinical Trials Site Director
Lovelace Respiratory Research Institute - Albuquerque, NM
Director, IT Global Operation Services, End-User Informatics Job
Celgene Corporation - Summit, NJ, US
Clinical Research Coordinator
Lovelace Respiratory Research Institute - Albuquerque, NM
Hematology Oncology Consultant, Hematology - Louisiana North Job
Celgene Corporation - Louisiana, LA, US
Analyst, Procurement Operations Job
Celgene Corporation - Basking Ridge, NJ, US

More Jobs >>

Events

CHI's Summit for Clinical Ops Executives (Scope)
February 7-9 — Miami
Life Science in the Cloud
Nov 16, 2011 — Cambridge, MA
Enforcement, Litigation and Compliance Conference
Dec. 6-7 — Washington, DC
Health Market Science Webinar: 3 Steps to New Physician Opportunities
Nov. 17

More Events >>

Related Tags >> CRO

Covance News

Most Popular Covance Story

SPOTLIGHT: Covance wins CRO award

May 8, 2008 — 5:59am ET

Covance, the inaugural sponsor of FierceVaccines, was recognized as the Best CRO at the 2008 World Vaccine Congress. The award recognizes for providing services that support vaccine development. Read more...

Covance Press Releases

New ACRO Member Survey Shows Growth of CRO Industry
PPD, Kendle and ICON Top CenterWatch’s 2011 Global CRO Report Card
Cenduit Sales Executive Appointed to Expand Business Development
Covance Expands Biotechnology Services into North America
Covance to Acquire Seattle-Based Gene Expression Laboratory from Merck & Co., Inc.

Latest Headlines

SPOTLIGHT: Covance wins CRO award
May 8, 2008

Paid Research Reports

Trends in mHealth and Telemedicine
The Global Aesthetic Dermatology Market Outlook
Future Directions in Regenerative Medicine
Pipeline Insight: Insulin Antidiabetics – Novel analogs show promise as alternative delivery methods prove less attractive
Pipeline Insight: Non-insulin Antidiabetics - Rise of the weight-reducers: Once-weekly GLP-1 agonists and novel SGLT-2 inhibitor
Forecast Insight: Antidiabetics - Diabetes market growth driven by epidemiological trends and rich pipeline

More Research Reports >>

THE FIERCEMARKETS NETWORK